Stock Track | Hims & Hers Health Soars 38.56% in Pre-Market on Novo Nordisk Partnership for Weight-Loss Drugs

Stock Track
03/09

Hims & Hers Health Inc. (HIMS) experienced a significant pre-market surge, with its stock price soaring 38.56%.

The dramatic move follows reports that Wegovy maker Novo Nordisk plans to sell its weight-loss drugs on the Hims & Hers telehealth platform. This new partnership brings an end to a dispute between the two companies that had escalated into a legal battle last month, removing a significant overhang and opening a substantial new revenue channel for the telehealth provider.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10